Cyclerion Therapeutics Inc (NASDAQ:CYCN) does about 713.37K shares in volume on a normal day but saw 985112 shares change hands in the recent trading day. The company now has a market cap of 6.07M USD. Its current market price is $2.20, marking an increase of 1.85% compared to the previous close of $2.16. The 52 week high reached by this stock is $5.25 whilst the lowest price level in 52 weeks is $1.27.
Cyclerion Therapeutics Inc (CYCN) has a 20-day trading average at $2.13 and the current price is -58.10% off the 52-week high compared with 73.23% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.47 and its 200-day simple moving average is $2.83. If we look at the stock’s price movements over the week, volatility stands at 18.73%, which increases to 24.48% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 50.37 to suggest the stock is neutral.
The consensus objective for the share price is $80.00, suggesting that the stock has a potential upside of 97.25% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on October 20, 2021 when Truist initiated the stock to “Buy” and issued a price target of $14.
The current price level is 3.28%, -11.02%, and -22.19% away from its SMA20, SMA50, and SMA200 respectively, with the CYCN price moving above the 50-day SMA on current market day. Cyclerion Therapeutics Inc (CYCN) stock is up 54.93% over the week and -26.67% over the past month. Its price is -34.33% year-to-date and -9.84% over the past year.
To reach the target analysts have set, the stock logically needs to grow 97.25 percent from here.
The company has a return on investment of -64.42% and return on equity of -50.13%. The beta has a value of 1.88. Price to book ratio is 0.68 and price to sales ratio is 31.95.
